Researchers found a new method to detect serious liver disease earlier by analyzing existing blood test data from the NHS. This approach, called the Cumulative Liver Damage Index (CLDI), assesses how liver damage has accumulated over time, rather than relying on single blood tests that only show a snapshot of liver health. The findings were presented at a European liver congress and could significantly improve early detection of liver disease, which is increasingly becoming a leading cause of death in the UK.

For people concerned about their health and longevity, this new method could mean earlier identification of liver issues, allowing for timely intervention before the disease progresses to advanced stages. The study involved nearly 1,000 participants and demonstrated that CLDI was more effective than standard tests in identifying individuals with significant liver disease. This could lead to better health outcomes, as early detection often means more treatment options and a higher chance of managing the disease effectively.

The research is in its early stages, having been conducted at a single NHS site with 994 participants. While the results are promising, further validation is needed through larger studies, including an ongoing trial involving 8,000 patients. This means that while the findings are encouraging, they are not yet fully proven for widespread clinical use.

As this method becomes more widely available, people should consider discussing liver health with their healthcare providers, especially if they have risk factors for liver disease. Keeping track of liver health and being proactive can lead to better long-term outcomes.

Source: globenewswire.com